Oral Glucose-Lowering Agent Treatments in Type 2 Diabetes Mellitus
نویسندگان
چکیده
Type 2 diabetes is manifested by impaired insulin secretion in pancreatic beta cells, increased glucagon alpha and generally has a history of resistance. The treatment glucose metabolism disorder the resulting hyperglycemia constitute an important part type diabetes. Glycemic targets can be targeted with A1C
منابع مشابه
Glucose-lowering medicines for type 2 diabetes.
BACKGROUND There is an increasing array of medicines available to improve blood glucose control in type 2 diabetes. Finding the best combination for an individual patient requires an assessment of the patient's characteristics and understanding the mechanism of action for each drug. OBJECTIVE The aim of this article is to provide a rational approach for choosing between the various blood gluc...
متن کاملEvaluation of Fasting Blood Sugar via Salivary Glucose in Type 2 Diabetes Mellitus
Objective: Diabetes mellitus (DM) as an ongoing metabolic disorder worldwide is a major public health concern. Diagnosis of DM is depended on clinical symptoms and laboratory findings. Fasting blood glucose (FBG) monitoring is currently the most common diagnostic method, which is an invasive and stressful procedure. Most recently, the use of non-invasive, convenient methods like fasting salivar...
متن کاملUpdate in internal medicine: intensive glucose lowering does not reduce mortality in type 2 diabetes mellitus.
After several large RCTs did not succeed in showing mortality or cardiovascular benefits with intensive glucose control in patients with type 2 diabetes mellitus, two recent metaanalysis confirmed this (1,2). They were performed on 14 and 13 randomized controlled trials, including 28,600 and 34,500 patients, respectively. The risks of myocardial infarction, a composite of microvascular outcomes...
متن کاملInitiation of glucose-lowering therapy in Type 2 diabetes mellitus patients in general practice.
AIM The purpose of this study was to investigate which factors determine the initiation of glucose-lowering therapy in patients with Type 2 diabetes mellitus in general practice and their future glycaemic control. METHODS All incident Type 2 diabetic patients in the general practices in a Dutch middle-sized town from 1994 to 2000 were identified. Factors associated with initiation of glucose-...
متن کاملPrevalence of Anti Hyperglycemic Agents -Associated Oral Lichenoid Lesions in Type 2 Diabetes Mellitus Patients
Objective: This study aimed to estimate the prevalence of lichenoid reactions to Anti Hyperglycemic Agents. Materials and Methods: In this cross-sectional descriptive and analytic study, we examined the oral mucosa of 411 patients at the age of 29 to 85 in 3 groups who consumed various antihyperglycemic agents. Results: In overall, 31 patients had lichenoid reactions (12 patients taking glibe...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Turkish journal of internal medicine
سال: 2021
ISSN: ['2687-4245']
DOI: https://doi.org/10.46310/tjim.815794